Article
Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.
Human immunology - 1 Nov 1999
Livingston B D, Crimi C, Fikes J, Chesnut R W, Sidney J, Sette A
Abstract excerpt
The human leukocyte antigen (HLA)-A2 restricted HBV core 18-27 epitope is immunodominant in the context of HLA-A2.1 and subdominant in the context of the other HLA-A2 supertype molecules, as defined by frequency of recognition by memory cytotoxic T lymphocyte (CTL) responses from acute hepatitis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
